Showing results (41-50 of 155) with videos related to
Sort By:
Pageof 16
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 1, 2000
Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureusP A Moise, A Forrest, S M Bhavnani, et al.Antimicrobial Agents and Chemotherapy|July 2, 2008
Association of fluconazole pharmacodynamics with mortality in patients with candidemiaJohn W Baddley, Mukesh Patel, Sujata M Bhavnani, et al.Antimicrobial Agents and Chemotherapy|December 30, 2015
Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit ConsiderationsSujata M Bhavnani, Paul G Ambrose, Jeffrey P Hammel, et al.British Journal of Haematology|August 1, 1997
The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic populationA M Cumming, S Keeney, A Salden, et al.Antimicrobial Agents and Chemotherapy|August 30, 2005
Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenemSujata M Bhavnani, Jeffrey P Hammel, Brenda B Cirincione, et al.Diagnostic Microbiology and Infectious Disease|January 21, 2006
Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance ProgramSujata M Bhavnani, Paul G Ambrose, William A Craig, et al.Journal of Chemotherapy (Florence, Italy)|February 21, 2007
Re-evaluation of the role of broad-spectrum cephalosporins against staphylococci by applying contemporary in-vitro results and pharmacokinetic-pharmacodynamic principlesH S Sader, S M Bhavnani, P G Ambrose, et al.Antibiotics (Basel, Switzerland)|July 19, 2020
Antibacterial Drug Development: A New Approach Is Needed for the Field to Survive and ThriveM Courtney Safir, Sujata M Bhavnani, Christine M Slover, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 1999
Influence of fluoroquinolone purchasing patterns on antimicrobial expenditures and Pseudomonas aeruginosa susceptibilityR P Rifenburg, J A Paladino, S M Bhavnani, et al.Diagnostic Microbiology and Infectious Disease|October 12, 2004
Pharmacokinetics, safety, and tolerability of ascending single intravenous doses of oritavancin administered to healthy human subjectsSujata M Bhavnani, Joel S Owen, Jeffery S Loutit, et al.Pageof 16